The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.
The PBM also announced that it will make the pharmacy experience simpler for consumers with chronic conditions by eliminating ...
The changes come as pharmacy benefit managers face scrutiny for how they require doctors and patients to seek its approval for certain treatments and drugs.
Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager ...
The representatives from the Leukemia & Lymphoma Society and HIV+Hepatitis Policy are asking state insurance regulators to ...
Optum Rx's new cost-based program uses an internal algorithm that leverages multiple available industry data sources, such as ...
UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get insurance ...
The PBM plans to stop requiring coverage authorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...
Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. | Optum ...
The massive pharmacy benefit manager plans to stop requiring coverage authorizations for roughly 80 drugs used to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results